The state has made strides in addressing the opioid crisis in recent years, but methamphetamine use — often in combination with other substances — is creating new challenges.

New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.